Blood 94:322b, 1999
Track Record: Semaglutide has been in clinical use longer and has more long-term safety data
When administered as a once-weekly subcutaneous injection, Ozempic helps to: Stimulate insulin secretion from the pancreas in response to elevated blood glucose levels Suppress glucagon release , reducing the liver's production of glucose Slow gastric emptying , which helps control post-meal blood sugar spikes Reduce appetite , often leading to weight loss as a secondary benefit The mechanism of action centres on the GLP-1 receptor, which is found in various tissues including the pancreas, brain, and gastrointestinal tract
The four substitutions (Tyr1, D-Ala2, Ala8, Ala15) in both variants protect against DPP-IV enzymatic cleavage at position 2 and general proteolytic degradation, providing improved stability over native GHRH
Reine Wirkstoffe sonst nichts: Citrullin, Arginin, Ornithin, Amaranthus (Oxystorm), Taurin, L-Tyrosin, Glutathion, Koffein